Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5882915 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 8 Pages |
Abstract
Compared with intensive induction, CLDA offers equivalent responses and survival but less toxicity in clinically well-matched cohorts of elderly AML patients. Prospective randomized trials to confirm these findings are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Koichi Takahashi, Hagop Kantarjian, Guillermo Garcia-Manero, Gautam Borthakur, Tapan Kadia, Courtney DiNardo, Elias Jabbour, Sherry Pierce, Zeev Estrov, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge Cortes,